Avid Bioservices Inc (CDMO)

[pphmtoolong]

My question, does Peregrine act like they expect Sunrise to propel the company to the next level or not? The evidence can be interpreted both ways in my view.

For instance, Avid could be expanded to support a commercial Bavi launch or as a money maker to keep Peregrine afloat while management brings along Bavi in other indications.

Another ambiguous item. Bavi is being tested in melanoma, and new trials are coming in breast cancer. Do these items represent an attempt to broaden Bavi's clinical area or do they represent Plan Bs for a Sunrise disappointment.

My sense is Peregrine management knows enough about the Sunrise trial to predict the Bavi arm patients are living long enough to warrant FDA approval and success in the clinical market place.

Just a few more months to find out. Looking at the share price the wait will be nerve wracking.

GLTA, Especially Bavi-arm Sunrise Patients,

Paul